FGFR INHIBITORS AND METHODS OF USE THEREOF
Abstract:
The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of FGFR enzymes with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with FGFR signaling with the compounds and compositions of the disclosure.
Public/Granted literature
Information query
Patent Agency Ranking
0/0